Willis C. Lee - 10 May 2021 Form 4 Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Role: Vice Chairman & COO, Director
Signature: Willis C. Lee
Issuer symbol: EMMA
Transactions as of: 10 May 2021
Net transactions value: +$16,395
Form type: 4
Filing time: 12 May 2021, 18:28:43 UTC
Previous filing: 07 May 2021
Next filing: 28 May 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EMMA	Common stock, $0.001 par value	Purchase	$1,710	+1,500	+0.66%	$1.14	228,724	10 May 2021	Direct
transaction	EMMA	Common stock, $0.001 par value	Purchase	$14,685	+13,350	+5.8%	$1.10	242,074	12 May 2021	Direct	F1
holding	EMMA	Common stock, $0.001 par value						108,761	10 May 2021	By Fidelity Traditional IRA FBO Willis C. Lee

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.10 to $1.20, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).

Content

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.10 to $1.20, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).